Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
(5S)-2-(Cyclooctylamino)-5-methyl-5-propyl-1,3-thiazol-4(5H)-one
- Development stage
- Unknown
- Modality
- Small Molecules
01
Overview
(5S)-2-(Cyclooctylamino)-5-methyl-5-propyl-1,3-thiazol-4(5H)-one is an experimental small molecule belonging to the thiazoline class of heterocyclic compounds. It has a molecular formula of C15H26N2OS and a molecular weight of approximately 282.45 g/mol[1][2]. The compound is not approved for clinical use in any country and has no known marketed indications or brand names. According to DrugBank, it is classified as an experimental agent with no completed or ongoing clinical trials[1]. Its primary reported biological target is 11-beta-hydroxysteroid dehydrogenase 1 (11β-HSD1), suggesting potential utility in modulating glucocorticoid metabolism; however, there are no published data on its efficacy or safety in humans[1].
- Other names
- (5S)-2-(cyclooctylamino)-5-methyl-5-propyl-1,3-thiazol-4(5H)-one4(5H)-Thiazolone, 2-(cyclooctylamino)-5-methyl-5-propyl-, (5S)
02
Targets
HSD11B1 (11-beta-hydroxysteroid dehydrogenase type 1)
Beyond the preview
Go deeper on (5S)-2-(Cyclooctylamino)-5-methyl-5-propyl-1,3-thiazol-4(5H)-one.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on (5S)-2-(Cyclooctylamino)-5-methyl-5-propyl-1,3-thiazol-4(5H)-one.